Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Syphilis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Syphilis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barquinero, J; Khamashta, M; Ordi-Ros, J; Perez-Peman, P; Selva, A; Vilardell, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Syphilis

ArticleYear
Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.
    Lupus, 1994, Volume: 3, Issue:1

    Topics: Antibodies, Antiphospholipid; Antibody Specificity; Antiphospholipid Syndrome; Autoantibodies; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Platelet Activating Factor; Syphilis

1994